Topic summary
History of disordered eating and why it changes the conversation
This is a generated summary. It shows the 5 most-liked posts from a topic of 25, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
dr_okonkwo, post #2: the opening post answers the question as asked. The question underneath it is different. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially multiple endocrine neoplasia type 2) is an important screening question. Go to post
Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.
journalclub_wren, post #10: Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might trigger relapse. This population requires specialist input. Go to post
Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.
bench_peak, post #11: post #10 is right about the mechanism and I think understates the practical bit. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists. Go to post
Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is extrapolating beyond the data.
Read the full topic (25 posts)
This topic was referenced in
- Pregnancy and pregnancy planning: contraindication and washoutClinical › Special populations · 122 replies
This topic was closed 180 days after the last reply. Closing is automatic for quiet topics so that a settled answer does not collect new questions underneath it. If you have a follow-up, open a new topic and link back to this one — that keeps both readable and gives your question its own title.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
|
+64 | 69 | 15k | 7mo |
|
About the Special populations category
Older adults, pregnancy and pregnancy planning, adolescents, renal and hepatic impairment, bariatric surgery history. This post is a community wiki: any member at trust level 3 or above can edit it, and every…
|
4 | 3k | 4mo | |
|
Athletes in weight-category sports: a different risk calculus — a second dataset
On the subject in the title: Athletes in weight-category sports: a different risk calculus — a second dataset Working notes rather than a conclusion. General question, not a request for advice about my own…
|
+37 | 41 | 16k | 20mo |
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold?
Asking directly, because I could not find a straight answer: Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? General question, not a request for advice about my own…
|
2 | 22k | 11mo | |
|
Coming back to: Bariatric surgery history: altered anatomy, altered expectations
Bariatric surgery history: altered anatomy, altered expectations Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
2 | 38k | 15mo |
Related topics — sharing the tags older adults, chronic kidney disease, adolescents
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Anxiety in the first weeks: drug, situation, or both — what changed since
Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a…
|
+88 | 95 | 4.5k | 5mo |
|
Mood changes: monitoring, and when to involve a professional — what changed since
Mood changes: monitoring, and when to involve a professional — what changed since Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice…
|
+6 | 10 | 45k | 25d |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+18 | 25 | 1.7k | 22mo |
|
Revisiting: Absolute versus relative contraindications
Revisiting: Absolute versus relative contraindications — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+80 | 85 | 7.4k | 3mo |
|
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 16k | 12h |